Castor

Executive Summary

Castor is a US-based digital health company that offers a unified electronic clinical data management platform, integrating eClinical tools such as Electronic Data Capture (EDC), ePRO/eCOA, eConsent, and decentralized trial (DCT) solutions. Founded in 2012 and headquartered in New York, Castor serves biopharma, medical device companies, CROs, and academic researchers, streamlining clinical trial execution. The platform's comprehensive suite addresses the growing demand for efficient, patient-centric trial management, particularly as decentralized and hybrid trials gain traction. Despite its established presence, Castor remains private with no disclosed funding or valuation, suggesting potential for growth capital or strategic partnerships to scale its offerings. Castor operates in a competitive landscape alongside players like Medidata, Veeva, and IBM Watson Health, but differentiates through its integrated, end-to-end approach and focus on user experience. The company's categorization in AI/ML indicates potential enhancements for data analytics and trial optimization. As clinical trials increasingly adopt digital tools, Castor is well-positioned to capture market share, especially among mid-tier biopharma and academic institutions. Its next growth phase likely hinges on product innovation, geographic expansion, or a significant funding event to accelerate commercialization and R&D.

Upcoming Catalysts (preview)

• Q3 2026Launch of AI-Powered Analytics Module70% success
• Q4 2026Strategic Partnership with Top-10 Pharma or CRO60% success
• TBDSeries C Funding Announcement50% success